CN104276960B - 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 - Google Patents

盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 Download PDF

Info

Publication number
CN104276960B
CN104276960B CN201410500983.5A CN201410500983A CN104276960B CN 104276960 B CN104276960 B CN 104276960B CN 201410500983 A CN201410500983 A CN 201410500983A CN 104276960 B CN104276960 B CN 104276960B
Authority
CN
China
Prior art keywords
pain
eutectic
celecoxib
tapentadol hydrochloride
tapentadol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410500983.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN104276960A (zh
Inventor
徐奎
刘丽
刘经星
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Heal Star Pharmaceutical Co.,Ltd.
Original Assignee
Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd filed Critical Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd
Priority to CN201410500983.5A priority Critical patent/CN104276960B/zh
Publication of CN104276960A publication Critical patent/CN104276960A/zh
Application granted granted Critical
Publication of CN104276960B publication Critical patent/CN104276960B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

CN201410500983.5A 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 Active CN104276960B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410500983.5A CN104276960B (zh) 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410500983.5A CN104276960B (zh) 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Publications (2)

Publication Number Publication Date
CN104276960A CN104276960A (zh) 2015-01-14
CN104276960B true CN104276960B (zh) 2016-09-28

Family

ID=52252364

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410500983.5A Active CN104276960B (zh) 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Country Status (1)

Country Link
CN (1) CN104276960B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107595792A (zh) * 2017-11-06 2018-01-19 刘丽 一种盐酸他喷他多塞来昔布片剂及其制备方法
CN112807315A (zh) * 2021-01-18 2021-05-18 江苏谛奇医药科技有限公司 塞来昔布和盐酸他喷他多低共熔混合物、含其的药物组合物及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009067706A1 (en) * 2007-11-21 2009-05-28 Oxigene, Inc. Method for treating hematopoietic neoplasms
CN102036946A (zh) * 2008-05-21 2011-04-27 埃斯蒂文博士实验室股份有限公司 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体
CN102188365A (zh) * 2011-05-11 2011-09-21 中山大学 一种难溶性药物共晶固体分散体及其制备方法
WO2011151080A1 (en) * 2010-06-04 2011-12-08 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1685829T1 (sl) * 2002-11-22 2008-08-31 Gruenenthal Gmbh Uporaba (1RS,3RS,6RS)-6-dimetilaminometil-1- (3-metoksi-fenil)-cikloheksan-1, 3-diola za zdravljenje vnetne bolečine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009067706A1 (en) * 2007-11-21 2009-05-28 Oxigene, Inc. Method for treating hematopoietic neoplasms
CN102036946A (zh) * 2008-05-21 2011-04-27 埃斯蒂文博士实验室股份有限公司 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体
WO2011151080A1 (en) * 2010-06-04 2011-12-08 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs
CN102188365A (zh) * 2011-05-11 2011-09-21 中山大学 一种难溶性药物共晶固体分散体及其制备方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Computational identification of a phospholipidosis toxicophore using 13C and 15N NMR-distance based fingerprints;Slavov,Svetoslav H. 等;《Bioorganic & Medicinal Chemistry》;20140827;第22卷(第23期);第6706-6714页 *
How Does the Quality of Phospholipidosis Data Influence the Predictivity of Structural Alerts?;Przybylak,Katarzyna R. 等;《Journal of Chemical Information and Modeling》;20140725;第54卷(第8期);第2224-2232页 *
共结晶技术和应用;许喜林 等;《甘蔗糖业》;20001225(第6期);第33-36页 *
新的晶体生长方法-共结晶化;张正之 等;《化学通报》;19900501(第4期);第18-19页 *

Also Published As

Publication number Publication date
CN104276960A (zh) 2015-01-14

Similar Documents

Publication Publication Date Title
TW202333743A (zh) (s)-2-乙基丁基2-(((s)-(((2r,3s,4r,5r)-5-(4-胺基吡咯并[2,1-f] [1,2,4]三嗪-7-基)-5-氰基-3,4-二羥基四氫呋喃-2-基)甲氧基)(苯氧基)磷醯基)胺基)丙酸酯之結晶形式
US9527833B2 (en) Stable crystal form of tipiracil hydrochloride and crystallization method for the same
Wang et al. Cocrystallization of amantadine hydrochloride with resveratrol: the first drug–nutraceutical cocrystal displaying synergistic antiviral activity
CN104276960B (zh) 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法
AU2015201141A1 (en) Aildenafil citrate crystal form O, preparation method and use thereof
CN108530425A (zh) 一种尼拉帕尼对甲苯磺酸盐水合物晶型及其制备方法
Gołdyn et al. Novel purine alkaloid cocrystals with trimesic and hemimellitic acids as coformers: Synthetic approach and supramolecular analysis
Gao et al. Drug-drug salt forms of vortioxetine with mefenamic acid and tolfenamic acid
CN104447904B (zh) 一种口服生物利用度高的稳定天麻素晶体及其制备方法、制剂与应用
CN101331112B (zh) 一种联苯乙酸盐及其制备方法与应用
CN103214382A (zh) 一种盐酸甲氯芬酯化合物及其药物组合物
CN102718675B (zh) 阿戈美拉汀甲磺酸复合物及其制备方法
US10266523B2 (en) Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof
US20150141519A1 (en) Agomelatine sulfuric acid complex, and preparation method and application thereof
CN110804026B (zh) 1- (3- (3-（4-氯苯基）丙氧基)丙基)哌啶盐酸盐的合成方法
US10328029B2 (en) Pharmaceutical composition
CN103298784A (zh) 一种酪氨酸激酶抑制剂的盐形式
CN109232297A (zh) 芬乐胺晶b型、制备方法和其组合物与用途
CN102702187A (zh) 一种盐酸戊乙奎醚的新晶型及其制备方法
CN103655499B (zh) 一种稳定的晶x型阿戈美拉汀片剂及其制备方法
JP2022530028A (ja) ＰＬＫ４阻害剤である（１Ｒ，２Ｓ）－（Ｅ）－２－（３－（４－（（ｃｉｓ－２，６－ジメチルモルホリノ）メチル）スチリル）－１Ｈ－イミダゾール－６－イル）－５’－メトキシスピロ［シクロプロパン－１，３’－インドリン］－２’－オンフマル酸塩のＳ４結晶形
CN105982891A (zh) 阿利沙坦脂和脑啡肽酶抑制剂或其前药的药物组合物
CN107118254B (zh) 丹参酮ⅱa衍生物作为magl(单酰甘油酯酶)抑制剂的用途
US20140206874A1 (en) Crystal form i of salt of a dipeptidyl peptidase-iv inhibitor and preparation method and use same
CN107595792A (zh) 一种盐酸他喷他多塞来昔布片剂及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190203

Address after: 230000 No. 15 Weiwu Road, Baohe Industrial Zone, Hefei City, Anhui Province

Patentee after: Anhui Heal Star Pharmaceutical Co.,Ltd.

Address before: 230051 No. 15 Yan'an Road, Baohe Industrial Zone, Hefei City, Anhui Province

Patentee before: Anhui Province Yi Xinming Pharmaceutical Technology Co., Ltd